Point72 Europe (London) LLP Becton Dickinson & CO Transaction History

Point72 Europe (London) LLP

  • $1.48 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$225.07 - $246.17 $5.81 Million - $6.35 Million
-25,800 Reduced 37.63%
42,757 $9.99 Million
Q1 2024

May 15, 2024
SELL
$233.45 - $247.73 $2.67 Million - $2.83 Million
-11,430 Reduced 14.29%
68,557 $17 Million
Q4 2023

Feb 14, 2024
BUY
$232.24 - $267.23 $18.6 Million - $21.4 Million
79,987 New
79,987 $19.5 Million

Others Institutions Holding BDX

# of Institutions
1,734
Shares Held
249M
Call Options Held
690K
Put Options Held
787K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $69.4B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Point72 Europe (London) LLP Portfolio

Follow Point72 Europe (London) LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Europe (London) LLP, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Europe (London) LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email